Stock Groups

Illumina says it had expected EU hold order on Grail By Reuters

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: This photograph shows a building at Illumina’s campus, San Diego, California. It was taken on September 1, 2021. REUTERS/Mike Blake

BRUSSELS (Reuters) – U.S. life sciences company Illumina (NASDAQ:) said on Monday that it had anticipated an order from EU antitrust enforcers to keep recently acquired Grail as a separate company while waiting for regulatory clearance of the deal.

In the days ahead, the company stated that it will discuss the European Commission’s suggestions. Although the EU competition enforcer earlier Monday stated it planned to take interim steps against the company in the wake of the closing prematurely, it did not give details.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are provided by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]